Keene & Associates’s Medtronic MDT Stock Holding History

Keene & Associates’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$3.17M	Buy	39,649 +708	+2%	+$61.3K	2.54%	18
2024 Q3	$3.51M	Buy	38,941 +127	+0.3%	+$10.7K	2.66%	19
2024 Q2	$3.06M	Buy	38,814 +103	+0.3%	+$8.44K	2.49%	25
2024 Q1	$3.37M	Sell	38,711 -214	-0.5%	-$18.3K	2.52%	21
2023 Q4	$3.21M	Sell	38,925 -364	-0.9%	-$27.7K	2.66%	14
2023 Q3	$3.08M	Buy	39,289 +195	+0.5%	+$16.3K	2.47%	15
2023 Q2	$3.44M	Sell	39,094 -142	-0.4%	-$12.2K	2.68%	15
2023 Q1	$3.16M	Buy	39,236 +22,386	+133%	+$1.82M	2.45%	22
2022 Q4	$1.31M	Sell	16,850 -15,492	-48%	-$1.26M	1.17%	29
2022 Q3	$2.61M	Buy	32,342 +1,358	+4%	+$122K	2.4%	22
2022 Q2	$2.78M	Buy	30,984 +910	+3%	+$92.2K	2.6%	20
2022 Q1	$3.34M	Buy	+30,074	New	+$3.18M	2.72%	18

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Keene & Associates's MDT Position: Q4 2024 in Review

Keene & Associates increased its Medtronic (MDT) stake by 1.8% in Q4 2024, buying an estimated $61.3K and bringing the position to 39,649 shares worth $3.17M. The position accounts for 2.54% of the portfolio, ranked #18.

Keene & Associates first reported a position in MDT in Q1 2022 and has held it in 12 quarters since. The position peaked at $3.51M in Q3 2024. 2,123 funds tracked by Wall St. Rank hold MDT as of Q4 2024.

Keene & Associates held 39,649 shares of Medtronic worth $3.17M as of Q4 2024.
Keene & Associates bought 708 Medtronic shares in Q4 2024, an estimated $61.3K.
Medtronic made up 2.54% of Keene & Associates's portfolio in Q4 2024, its #18 holding.
Keene & Associates first reported a position in Medtronic in Q1 2022 and has held it in 12 quarters since.
Keene & Associates's Medtronic position peaked at $3.51M in Q3 2024.
2,123 funds tracked by Wall St. Rank held Medtronic as of Q4 2024.

Based on Keene & Associates's 13F filing for Q4 2024, filed 3 Feb 2025.